Such a scenario has also been reported for other cancer cell models, for instance, in A549 lung cancer cells, where the KD of TRPC1 decreased the protein expression of Cyclin D1 and D3, leading to an increased number of cells in the G1 phase [28]. This evidence concerns the gene TRPC1 and lung carcinoma.